{
    "RADCURE-3649": {
        "question": "Age: 81.0, Sex: Male, ECOG PS: ECOG-Pt 0, Smoking PY: 40, Smoking Status: Ex-smoker, Ds Site: Larynx, Subsite: Supraglottis, T: T2, N: N2b, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: Negative, Tx Modality: RT alone, Chemo? : none, Dose: 60.0, Fx: 25, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical spine, oropharyngeal airway, base of tongue, and soft tissues of the neck.\n- The spinal cord and vertebral bodies are visible posteriorly.\n- The airway appears patent without obvious obstruction.\n- The masked region of interest (ROI) is located anteriorly in the oropharyngeal region, likely involving soft tissue structures around the base of tongue or oropharynx.\n- The ROI appears as a highlighted area with increased density relative to surrounding soft tissue, suggesting a pathological lesion or tumor.\n- No obvious gross bone destruction or large lymphadenopathy is visible in this single slice.\n- No clear signs of distant metastasis or gross invasion into adjacent critical structures are noted here.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates are given as:\n\n1. [264, 222, 117, 264, 254, 145]\n2. [254, 191, 75, 254, 213, 84]\n\nThese coordinates represent minimum and maximum values along z, y, and x axes, normalized to the image size.\n\n- The first bounding box (264-264 in z, 222-254 in y, 117-145 in x) likely corresponds to a volumetric region in the oropharyngeal soft tissues, possibly encompassing the primary tumor or involved lymph nodes.\n- The second bounding box (254-254 in z, 191-213 in y, 75-84 in x) is smaller and more anterior, possibly representing a smaller lesion or a lymph node in the neck.\n\nMapping these onto the scan, these boxes likely correspond to:\n\n- Primary tumor site in the oropharynx or base of tongue.\n- Regional lymph node involvement in the neck.\n\n**Step 3: Clinical Reasoning**\n\n- The patient has a lesion in the oropharyngeal region, consistent with squamous cell carcinoma (common in this area).\n- The presence of two bounding boxes suggests both a primary tumor and regional nodal involvement.\n- The masked ROI corresponds to the primary tumor site.\n- No gross distant metastasis is visible on this scan.\n- The involvement of regional lymph nodes (second bounding box) indicates at least N1 or higher nodal stage.\n- The absence of bone invasion or airway obstruction is favorable for local control.\n- Given the location and involvement, radiation therapy planning should focus on the primary tumor and involved nodal regions.\n- HPV status is not provided here but is critical for prognosis; HPV-positive oropharyngeal cancers have better outcomes.\n- The patient's survival probability depends on tumor stage, nodal involvement, HPV status, and treatment modality.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a primary oropharyngeal tumor with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor.\n- Bounding boxes delineate the tumor and involved lymph nodes.\n- No distant metastasis or gross invasion into critical structures is seen.\n- Radiation therapy should target both the primary and nodal volumes.\n- Prognosis depends on HPV status and treatment but nodal involvement suggests intermediate risk.\n- Close follow-up and possible combined modality treatment (RT + chemo) may be warranted.\n\n---\n\n**Answer: Alive**",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A diagnostic radiologist or head and neck radiologist is needed to provide detailed interpretation of the CT imaging findings, including tumor extent, nodal involvement, and possible invasion of adjacent structures. This expertise complements radiation therapy planning by ensuring accurate target delineation and staging. Additionally, a medical oncologist or head and neck surgeon may be helpful for comprehensive treatment planning and multidisciplinary management.",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a diagnostic radiologist or head and neck radiologist for detailed interpretation of CT imaging findings, including tumor extent, nodal involvement, and possible invasion of adjacent structures, to aid accurate target delineation and staging.  \n- Involve a medical oncologist or head and neck surgeon for comprehensive treatment planning and multidisciplinary management.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Diagnostic Radiologist (Head and Neck Radiologist) - Your expertise is strictly limited to detailed interpretation of CT imaging findings, including tumor extent, nodal involvement, and possible invasion of adjacent structures in head and neck cancers. - Hierarchy: Diagnostic Radiologist == Radiation Oncologist\n2. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions and multidisciplinary treatment planning in head and neck squamous cell carcinoma. - Hierarchy: Medical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-diagnostic radiologist (head and neck radiologist)": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck, focusing on the laryngeal and supraglottic region.\n- Visible anatomical structures include the cervical vertebrae posteriorly, the airway (pharynx and larynx), and soft tissues of the neck.\n- The airway lumen appears patent without gross obstruction.\n- The masked region of interest (ROI) is located in the supraglottic larynx region, showing increased density compared to surrounding soft tissue, consistent with a pathological lesion.\n- No obvious gross bone or cartilage destruction is seen in this slice.\n- No large lymph nodes or distant metastases are visible in this single image.\n- The lesion appears localized to the supraglottic larynx without clear invasion into adjacent structures such as the base of tongue or hypopharynx.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n1. [264, 222, 117, 264, 254, 145]\n2. [254, 191, 75, 254, 213, 84]\n\n- These coordinates correspond to volumetric regions within the scan.\n- The first bounding box (z=264, y=222-254, x=117-145) likely encompasses the primary tumor in the supraglottic larynx.\n- The second bounding box (z=254, y=191-213, x=75-84) is smaller and more anterior or inferior, possibly representing involved regional lymph nodes in the neck.\n- This correlates with the clinical staging of N2b (multiple ipsilateral lymph nodes).\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an 81-year-old male with a history of heavy smoking (40 pack-years), now ex-smoker.\n- Diagnosis: Squamous cell carcinoma of the supraglottic larynx, T2 (tumor limited to supraglottis with vocal cord mobility preserved), N2b (multiple ipsilateral lymph nodes), M0 (no distant metastasis), Stage IVA.\n- HPV negative status, which is associated with poorer prognosis compared to HPV-positive oropharyngeal cancers.\n- Treatment: Radiation therapy alone, 60 Gy in 25 fractions, no chemotherapy.\n- ECOG performance status 0 indicates good functional status.\n- The absence of local, regional, or distant recurrence at this time is favorable.\n- Nodal involvement (N2b) increases risk of regional failure and distant metastasis.\n- Radiation alone without chemotherapy in an elderly patient may be chosen due to comorbidities or patient preference.\n- Survival probability is moderate; advanced stage and nodal disease reduce survival, but good performance status and no distant disease are positive factors.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding boxes confirm a supraglottic laryngeal squamous cell carcinoma with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor in the supraglottic larynx.\n- No evidence of gross cartilage invasion or distant metastasis is seen.\n- Radiation therapy alone was administered, which may be less effective than combined modality but appropriate given patient factors.\n- Prognosis is guarded but not poor; the patientâ€™s good performance status and absence of distant disease support potential for disease control.\n- Close follow-up is essential due to nodal involvement and advanced stage.\n\n---\n\nAnswer: Alive",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region, focusing on the laryngeal and supraglottic area.\n- Visible anatomical structures include the cervical vertebrae posteriorly, the airway (pharynx and larynx), and soft tissues of the neck.\n- The airway appears patent without gross obstruction.\n- The masked region of interest (ROI) is located in the supraglottic laryngeal region, showing increased density compared to surrounding soft tissue, consistent with a pathological lesion.\n- No obvious gross bone destruction or invasion into the cervical spine is noted.\n- No large lymphadenopathy or distant metastasis is visible in this single slice.\n- The lesion appears localized to the supraglottic larynx.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n1. [264, 222, 117, 264, 254, 145]\n2. [254, 191, 75, 254, 213, 84]\n\n- Both bounding boxes have the same z-axis minimum and maximum values (264 and 254), indicating they are on adjacent or same axial slices.\n- The first bounding box (y: 222-254, x: 117-145) corresponds to a region in the supraglottic larynx, likely representing the primary tumor.\n- The second bounding box (y: 191-213, x: 75-84) is smaller and more anterior or lateral, likely representing involved regional lymph nodes in the neck.\n- These boxes correspond well with the clinical staging of T2 primary tumor in the supraglottis and N2b nodal involvement.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an 81-year-old male with a history of heavy smoking (40 pack-years), now ex-smoker.\n- Diagnosis: Squamous cell carcinoma of the supraglottic larynx, staged T2N2bM0, stage IVA.\n- HPV negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status 0 indicates good functional status.\n- Treatment: Radiation therapy alone (60 Gy in 25 fractions), no chemotherapy.\n- N2b nodal stage indicates multiple ipsilateral lymph nodes involved, increasing risk of regional recurrence.\n- Absence of chemotherapy may reduce systemic control, but patient age and comorbidities may have influenced this decision.\n- Radiation dose is standard for definitive treatment.\n- No evidence of distant metastasis or second primary cancer.\n- Prognosis is intermediate to poor due to nodal involvement, HPV negativity, and supraglottic site.\n- Survival probability is reduced compared to early-stage disease but may be acceptable given good performance status and treatment.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding boxes confirm a T2 supraglottic primary tumor with ipsilateral multiple nodal involvement (N2b).\n- The masked ROI corresponds to the primary tumor.\n- No distant metastasis or gross invasion into critical structures is seen.\n- Treatment with radiation alone is standard but may have limited efficacy in N2b disease without chemotherapy.\n- Patient's age and comorbidities likely influenced treatment choice.\n- Overall survival probability is moderate; risk of regional recurrence is significant.\n- Close follow-up is essential; consideration of salvage therapy if recurrence occurs.\n\n---\n\nAnswer: Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-diagnostic radiologist (head and neck radiologist)": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-role-comment": "radiation oncologist:alive|diagnostic radiologist (head and neck radiologist):alive|medical oncologist:alive",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}